Share |

PrintPrintable version



Obama Administration Responds by Pumping Another $1.2 Million Into HPV Vaccine Push

| | Comments (0)

The Liberty Beacon

Posted by: TLB Staff

January 9, 2014

Gardasil By: Carolanne Wright


201401091526.jpg

“After receiving her second dose of Gardasil … she could crawl but … needed to use crutches or a wheel chair … She experienced problems breathing and had ‘super migraines’ that never went away … She had swelling in her face, jaw and wrists. The patient was diagnosed with Guillain-Barre syndrome, myelin sheath degeneration and peripheral neuropathy. Patient was hospitalized twice … patient has not recovered from symptoms,” states a press release by Judicial Watch regarding documents obtained from the FDA’s Vaccine Adverse Event Reporting System (VAERS). Regrettably, this is only one of more than 6,000 registered adverse reactions connected with the vaccine, including over 100 deaths.

Troubled history

According to SaneVax, Gardarsil has a higher rate of side effects than any other CDC-recommended vaccine for children between the ages of seven and 18, as noted in this chart. Linked with cervical cancer, seizures, autoimmune disorders, blindness, paralysis and short-term memory loss, it’s astounding to learn that the vaccine was fast-tracked for approval by the FDA. Judicial Watch has compiled a special report on the approval process, side effects, safety concerns and marketing practices of Gardasil, which can be found here.

Following the U.S. government’s lead, Japanese officials also pushed the vaccine nationwide for “urgent HPV vaccination programs,” resulting in the allocation of 15 billion yen ($187.5 million) for the agenda. Junior high schools were targeted, and letters were sent to homes of girls within the vaccination age range. However, health officials began to notice a disturbing trend among the vaccinated girls, with 1,968 documented adverse events. Parents sent videos to the country’s health minister showing their daughters suffering from walking disturbances, seizures and body tics. Other cases reported that girls given the vaccine often fell to the floor, resulting in head injuries, some even fracturing their jaws and teeth. In response, Japan’s Vaccine Adverse Reactions Review Committee withdrew the recommendation for Gardasil and sent formal notifications to local governments, advising discontinuation of the vaccine until safety concerns were addressed.

In contrast, American health officials continue to promote Gardasil. Judicial Watch discovered that just “weeks after Japan took action, the Obama administration dedicated $1.2 million to ‘increase HPV vaccine uptake in low income ethnic minority populations’ in Spanish, Cantonese, Mandarin, Armenian and Korean.”

As aptly observed by Judicial Watch president Tom Fitton, “The FDA is supposed to be a guardian of public health, and yet the agency continues to turn a blind eye to what seems to be an extremely serious public health problem. The public relations push for Gardasil by Merck, politicians and public health officials needs to pause so that these adverse reactions can be further studied.” He further asserts that “[t]he already serious problems associated with Gardasil seem to be getting worse. No one should require this vaccine for young children.”

Sources:

http://www.judicialwatch.org

http://sanevax.org

http://www.judicialwatch.org

http://science.naturalnews.com

http://science.naturalnews.com

About the author: Carolanne believes if we want to see change in the world, we need to be the change. As a nutritionist, natural foods chef and wellness coach, she has encouraged others to embrace a healthy lifestyle of green living for over 13 years. Through her website www.Thrive-Living.net, she looks forward to connecting with other like-minded people who share a similar vision.

See original here: http://www.naturalnews.com/043447_Gardasil_Obama_administration_HPV_vaccine.html



  • Currently 4/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 4/5 (4 votes cast)




Leave a comment

Health Supreme News

Loading...
Powered by Movable Type 5.13-en

Receive updates

Subscribe to get updates of this site by email:

Enter your Email


Preview | Powered by FeedBlitz

Other sites of ours